Meta-analysis compares post-acute risks after SARS-CoV-2 versus other respiratory viral infections

This publication is a systematic review and meta-analysis that examines the comparative risks of persistent symptoms or conditions following SARS-CoV-2 infection versus other acute respiratory viral infections in adults. It included 22 studies, with 14 contributing to the meta-analysis, focusing on post-acute infection syndromes such as post-COVID-19 condition. The review synthesizes observational evidence to assess pooled risks across various health outcomes.

The meta-analysis identified increased risks after SARS-CoV-2 infection for several specific outcomes: pulmonary embolism, abnormal breathing, fatigue, hemorrhagic stroke, memory loss/brain fog, and palpitations. For heart rate abnormalities, the pooled estimate showed borderline significance. However, for most other outcomes evaluated, the pooled estimates were inconclusive, indicating limited or inconsistent evidence across studies. No specific effect sizes, absolute numbers, p-values, or confidence intervals were reported for these findings.

The authors do not explicitly note limitations in the provided data, but the reliance on observational studies and the inconclusive results for many outcomes suggest inherent uncertainties. Safety data, follow-up duration, and detailed study settings were not reported. In practice, this review highlights patterns of increased risk for certain post-acute conditions after SARS-CoV-2 infection compared to other viral infections, but clinicians should consider the observational nature and variability in evidence when applying these findings to patient care.